126 related articles for article (PubMed ID: 34920739)
1. An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors.
Nwanaji-Enwerem JC; Chung FF; Van der Laan L; Novoloaca A; Cuenin C; Johansson H; Bonanni B; Hubbard AE; Smith MT; Hartman SJ; Cardenas A; Sears DD; Herceg Z
Clin Epigenetics; 2021 Dec; 13(1):224. PubMed ID: 34920739
[TBL] [Abstract][Full Text] [Related]
2. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.
Patterson RE; Marinac CR; Natarajan L; Hartman SJ; Cadmus-Bertram L; Flatt SW; Li H; Parker B; Oratowski-Coleman J; Villaseñor A; Godbole S; Kerr J
Contemp Clin Trials; 2016 Mar; 47():64-71. PubMed ID: 26706665
[TBL] [Abstract][Full Text] [Related]
3. The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study.
Hartman SJ; Nelson SH; Marinac CR; Natarajan L; Parker BA; Patterson RE
Psychooncology; 2019 Aug; 28(8):1640-1646. PubMed ID: 31140202
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials.
Bellerba F; Chatziioannou AC; Jasbi P; Robinot N; Keski-Rahkonen P; Trolat A; Vozar B; Hartman SJ; Scalbert A; Bonanni B; Johansson H; Sears DD; Gandini S
J Transl Med; 2022 Dec; 20(1):629. PubMed ID: 36581893
[TBL] [Abstract][Full Text] [Related]
5. Body weight management in overweight and obese breast cancer survivors.
Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study.
El-Attar AA; Ibrahim OM; Alhassanin SA; Essa ES; Mostafa TM
Eur J Clin Pharmacol; 2023 Feb; 79(2):299-309. PubMed ID: 36562831
[TBL] [Abstract][Full Text] [Related]
7. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors.
Toriola AT; Liu J; Ganz PA; Colditz GA; Yang L; Izadi S; Naughton MJ; Schwartz AL; Wolin KY
Breast Cancer Res Treat; 2015 Aug; 152(3):637-43. PubMed ID: 26175059
[TBL] [Abstract][Full Text] [Related]
8. Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol.
Sedlacek SM; Playdon MC; Wolfe P; McGinley JN; Wisthoff MR; Daeninck EA; Jiang W; Zhu Z; Thompson HJ
BMC Cancer; 2011 Jul; 11():287. PubMed ID: 21733177
[TBL] [Abstract][Full Text] [Related]
9. Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors.
Pakiz B; Flatt SW; Bardwell WA; Rock CL; Mills PJ
Int J Behav Med; 2011 Dec; 18(4):333-41. PubMed ID: 21336679
[TBL] [Abstract][Full Text] [Related]
10. The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema.
Winkels RM; Sturgeon KM; Kallan MJ; Dean LT; Zhang Z; Evangelisti M; Brown JC; Sarwer DB; Troxel AB; Denlinger C; Laudermilk M; Fornash A; DeMichele A; Chodosh LA; Schmitz KH
Contemp Clin Trials; 2017 Oct; 61():63-72. PubMed ID: 28739540
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.
Patterson RE; Marinac CR; Sears DD; Kerr J; Hartman SJ; Cadmus-Bertram L; Villaseñor A; Flatt SW; Godbole S; Li H; Laughlin GA; Oratowski-Coleman J; Parker BA; Natarajan L
J Natl Cancer Inst; 2018 Nov; 110(11):1239-1247. PubMed ID: 29788487
[TBL] [Abstract][Full Text] [Related]
12. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
13. A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design.
Di Meglio A; Martin E; Crane TE; Charles C; Barbier A; Raynard B; Mangin A; Tredan O; Bouleuc C; Cottu PH; Vanlemmens L; Segura-Djezzar C; Lesur A; Pistilli B; Joly F; Ginsbourger T; Coquet B; Pauporte I; Jacob G; Sirven A; Bonastre J; Ligibel JA; Michiels S; Vaz-Luis I
Trials; 2022 Mar; 23(1):193. PubMed ID: 35246219
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density.
Tapia E; Villa-Guillen DE; Chalasani P; Centuori S; Roe DJ; Guillen-Rodriguez J; Huang C; Galons JP; Thomson CA; Altbach M; Trujillo J; Pinto L; Martinez JA; Algotar AM; Chow HS
Breast Cancer Res Treat; 2021 Nov; 190(1):69-78. PubMed ID: 34383179
[TBL] [Abstract][Full Text] [Related]
15. Testosterone and depressive symptoms among men in the Diabetes Prevention Program.
Kim C; Barrett-Connor E; Aroda VR; Mather KJ; Christophi CA; Horton ES; Pi-Sunyer X; Bray GA; Labrie F; Golden SH;
Psychoneuroendocrinology; 2016 Oct; 72():63-71. PubMed ID: 27371769
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study.
Rentscher KE; Bethea TN; Zhai W; Small BJ; Zhou X; Ahles TA; Ahn J; Breen EC; Cohen HJ; Extermann M; Graham DMA; Jim HSL; McDonald BC; Nakamura ZM; Patel SK; Root JC; Saykin AJ; Van Dyk K; Mandelblatt JS; Carroll JE
Cancer; 2023 Sep; 129(17):2741-2753. PubMed ID: 37259669
[TBL] [Abstract][Full Text] [Related]
17. Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial.
Yaskolka Meir A; Keller M; Bernhart SH; Rinott E; Tsaban G; Zelicha H; Kaplan A; Schwarzfuchs D; Shelef I; Gepner Y; Li J; Lin Y; Blüher M; Ceglarek U; Stumvoll M; Stadler PF; Stampfer MJ; Kovacs P; Liang L; Shai I
Clin Epigenetics; 2021 Mar; 13(1):48. PubMed ID: 33663610
[TBL] [Abstract][Full Text] [Related]
18. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.
Rock CL; Flatt SW; Byers TE; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Sedjo RL; Wyatt H
J Clin Oncol; 2015 Oct; 33(28):3169-76. PubMed ID: 26282657
[TBL] [Abstract][Full Text] [Related]
19. Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial.
Rock CL; Byers TE; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Sedjo RL; Wyatt H;
Contemp Clin Trials; 2013 Mar; 34(2):282-95. PubMed ID: 23266440
[TBL] [Abstract][Full Text] [Related]
20. Comparing Outcomes of a Digital Commercial Weight Loss Program in Adult Cancer Survivors and Matched Controls with Overweight or Obesity: Retrospective Analysis.
May CN; Ho AS; Yang Q; McCallum M; Iyengar NM; Comander A; Mitchell ES; Michaelides A
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
